{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T17:18:41Z","timestamp":1785777521902,"version":"3.56.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2009,11,10]],"date-time":"2009-11-10T00:00:00Z","timestamp":1257811200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Clin Oncol"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1038\/nrclinonc.2009.167","type":"journal-article","created":{"date-parts":[[2009,11,10]],"date-time":"2009-11-10T04:50:05Z","timestamp":1257828605000},"page":"699-706","source":"Crossref","is-referenced-by-count":33,"title":["Primary HPV screening for cervical cancer prevention: results from European trials"],"prefix":"10.1038","volume":"6","author":[{"given":"Elsebeth","family":"Lynge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matejka","family":"Rebolj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,11,10]]},"reference":[{"key":"BFnrclinonc2009167_CR1","unstructured":"IARC. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 90: Human Papillomaviruses (International Agency for Research on Cancer, Lyon, 2007)."},{"key":"BFnrclinonc2009167_CR2","unstructured":"IARC. IARC Handbooks of Cancer Prevention, Volume 10: Cervix cancer screening (International Agency for Research on Cancer, Lyon, 2005)."},{"key":"BFnrclinonc2009167_CR3","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.ygyno.2006.08.053","volume":"104","author":"G Koliopoulos","year":"2007","unstructured":"Koliopoulos, G.  et al. Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies. Gynecol. Oncol. 104, 232\u2013246 (2007).","journal-title":"Gynecol. Oncol."},{"issue":"Suppl. 10","key":"BFnrclinonc2009167_CR4","doi-asserted-by":"publisher","first-page":"K29","DOI":"10.1016\/j.vaccine.2008.06.019","volume":"26","author":"J Cuzick","year":"2008","unstructured":"Cuzick, J.  et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine 26 (Suppl. 10), K29\u2013K41 (2008).","journal-title":"Vaccine"},{"key":"BFnrclinonc2009167_CR5","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.ajog.2005.01.056","volume":"193","author":"K Elfgren","year":"2005","unstructured":"Elfgren, K.  et al. Colposcopic and histopathologic evaluation of women participating in population-based screening for human papillomavirus deoxyribonucleic acid persistence. Am. J. Obstet. Gynecol. 193, 650\u2013657 (2005).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"BFnrclinonc2009167_CR6","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1056\/NEJMoa073204","volume":"357","author":"P Naucler","year":"2007","unstructured":"Naucler, P.  et al. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N. Engl. J. Med. 357, 1589\u20131597 (2007).","journal-title":"N. Engl. J. Med."},{"key":"BFnrclinonc2009167_CR7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1093\/jnci\/djn444","volume":"101","author":"P Naucler","year":"2009","unstructured":"Naucler, P.  et al. Efficacy of HPV DNA testing with cytology triage and\/or repeat HPV DNA testing in primary cervical cancer screening. J. Natl Cancer Inst. 101, 88\u201399 (2009).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnrclinonc2009167_CR8","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/ijc.20076","volume":"110","author":"NW Bulkmans","year":"2004","unstructured":"Bulkmans, N. W.  et al. POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women. Int. J. Cancer 110, 94\u2013101 (2004).","journal-title":"Int. J. Cancer"},{"key":"BFnrclinonc2009167_CR9","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/S0140-6736(07)61450-0","volume":"370","author":"NW Bulkmans","year":"2007","unstructured":"Bulkmans, N. W.  et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet 370, 1764\u20131772 (2007).","journal-title":"Lancet"},{"key":"BFnrclinonc2009167_CR10","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S1470-2045(06)70731-8","volume":"7","author":"G Ronco","year":"2006","unstructured":"Ronco, G.  et al. Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial. Lancet Oncol. 7, 547\u2013555 (2006).","journal-title":"Lancet Oncol."},{"key":"BFnrclinonc2009167_CR11","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/jnci\/djj209","volume":"98","author":"G Ronco","year":"2006","unstructured":"Ronco, G.  et al. Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial. J. Natl Cancer Inst. 98, 765\u2013774 (2006).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnrclinonc2009167_CR12","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/jnci\/djn065","volume":"100","author":"G Ronco","year":"2008","unstructured":"Ronco, G.  et al. Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test. J. Natl Cancer Inst. 100, 492\u2013501 (2008).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnrclinonc2009167_CR13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/sj.bjc.6603210","volume":"95","author":"HC Kitchener","year":"2006","unstructured":"Kitchener, H. C.  et al. HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial. Br. J. Cancer 95, 56\u201361 (2006).","journal-title":"Br. J. Cancer"},{"key":"BFnrclinonc2009167_CR14","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/sj.bjc.6602799","volume":"93","author":"L Kotaniemi-Talonen","year":"2005","unstructured":"Kotaniemi-Talonen, L.  et al. Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting. Br. J. Cancer 93, 862\u2013867 (2005).","journal-title":"Br. J. Cancer"},{"key":"BFnrclinonc2009167_CR15","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.ejca.2007.12.002","volume":"44","author":"L Kotaniemi-Talonen","year":"2008","unstructured":"Kotaniemi-Talonen, L.  et al. Screening with a primary human papillomavirus test does not increase detection of cervical cancer and intraepithelial neoplasia 3. Eur. J. Cancer 44, 565\u2013571 (2008).","journal-title":"Eur. J. Cancer"},{"key":"BFnrclinonc2009167_CR16","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1056\/NEJMoa0808516","volume":"360","author":"R Sankaranarayanan","year":"2009","unstructured":"Sankaranarayanan, R.  et al. HPV screening for cervical cancer in rural India. N. Engl. J. Med. 360, 1385\u20131394 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFnrclinonc2009167_CR17","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/ijc.21897","volume":"119","author":"MH Mayrand","year":"2006","unstructured":"Mayrand, M. H.  et al. Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST). Int. J. Cancer 119, 615\u2013623 (2006).","journal-title":"Int. J. Cancer"},{"key":"BFnrclinonc2009167_CR18","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1056\/NEJMoa071430","volume":"357","author":"MH Mayrand","year":"2007","unstructured":"Mayrand, M. H.  et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N. Engl. J. Med. 357, 1579\u20131588 (2007).","journal-title":"N. Engl. J. Med."},{"key":"BFnrclinonc2009167_CR19","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/ijc.21611","volume":"118","author":"P Davies","year":"2006","unstructured":"Davies, P.  et al. A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening. Int. J. Cancer 118, 791\u2013796 (2006).","journal-title":"Int. J. Cancer"},{"key":"BFnrclinonc2009167_CR20","volume-title":"Statistical Models in Epidemiology","author":"D Clayton","year":"1993","unstructured":"Clayton, D. & Hills, M. Statistical Models in Epidemiology (Oxford University Press, Oxford, 1993)."},{"key":"BFnrclinonc2009167_CR21","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1002\/(SICI)1097-0258(19960715)15:13<1447::AID-SIM267>3.0.CO;2-V","volume":"15","author":"MA Chaudhary","year":"1996","unstructured":"Chaudhary, M. A. & Stearns, S. C. Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial. Stat. Med. 15, 1447\u20131458 (1996).","journal-title":"Stat. Med."},{"key":"BFnrclinonc2009167_CR22","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1002\/ijc.22838","volume":"121","author":"M Rebolj","year":"2007","unstructured":"Rebolj, M.  et al. Human papillomavirus triage of women with persistent borderline or mildly dyskaryotic smears: comparison of costs and side effects of three alternative strategies. Int. J. Cancer 121, 1529\u20131535 (2007).","journal-title":"Int. J. Cancer"},{"key":"BFnrclinonc2009167_CR23","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1002\/cncr.21823","volume":"106","author":"AL Svendsen","year":"2006","unstructured":"Svendsen, A. L.  et al. Breast cancer incidence after the introduction of mammography screening: what should be expected? Cancer 106, 1883\u20131890 (2006).","journal-title":"Cancer"},{"key":"BFnrclinonc2009167_CR24","unstructured":"National Cancer Institute. Cervical cancer screening: HPV testing [\n                    online\n                    \n                  ], (2009)."},{"key":"BFnrclinonc2009167_CR25","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1111\/j.1475-6773.2004.00265.x","volume":"39","author":"KM Rappaport","year":"2004","unstructured":"Rappaport, K. M.  et al. Adoption of liquid-based cervical cancer screening tests by family physicians and gynecologists. Health Serv. Res. 39, 927\u2013947 (2004).","journal-title":"Health Serv. Res."}],"container-title":["Nature Reviews Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrclinonc.2009.167.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrclinonc.2009.167","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrclinonc.2009.167.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:02:41Z","timestamp":1684468961000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrclinonc.2009.167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,10]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["BFnrclinonc2009167"],"URL":"https:\/\/doi.org\/10.1038\/nrclinonc.2009.167","relation":{},"ISSN":["1759-4774","1759-4782"],"issn-type":[{"value":"1759-4774","type":"print"},{"value":"1759-4782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,10]]}}}